Maximizing Social Media Engagement at 2018 BIO Investor Forum
Enhance your social media presence for the 2018 BIO Investor Forum with this comprehensive toolkit including suggested posts, hashtags, and key handles. Drive engagement, network effectively, and stay connected with industry updates before, during, and after the event in San Francisco. Elevate your online reach and showcase your participation at #BIF18, leveraging the latest in social media strategies provided in this toolkit.
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
You are allowed to download the files provided on this website for personal or commercial use, subject to the condition that they are used lawfully. All files are the property of their respective owners.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.
E N D
Presentation Transcript
2018 BIO INVESTOR FORUM SOCIAL MEDIA TOOLKIT October 17-18, 2018 San Francisco
OVERVIEW This toolkit gives you everything you need to discuss the 2018 BIF on social media, particularly on Twitter and Facebook. We encourage you to mention/tag #BIF18 and @IAmBiotech as you share content leading up to, during and after the event. Please use all or part of this kit to augment/supplement your existing social media plans for BIF 2018. Any irrelevant information should be discarded. With the exciting line up of speakers, endless networking opportunities and rich discussions on key issues affecting our industry and future, there will be many opportunities to share relevant and informative content to drive engagement and awareness of the work to which we are so proud to contribute.
HASHTAGS & HANDLES BIO HANDLES Twitter @IAmBiotech @BIO1x1 Facebook IAmBiotech HASHTAGS #BIF18 Key Voices Jim Greenwood @JimGreenwood (Twitter) @jamesgreenwood (Facebook)
2018 BIO INVESTOR FORUM PRE-EVENT SOCIAL POSTS
SUGGESTED POST #1 CAPTION SUGGESTIONS BIO Investor Forum #BIF18 Ready for #BIF18! Are you attending? Heading to #BIF18 in #SanFrancisco. Follow along @IAmBiotech Excited to see [insert speaker twitter handle] at #BIF18 To use: Right click and save as picture
SUGGESTED POST #2 Examples for Blank 1: @angelemaki , or @ThirdRockV or any individual or organization you choose This week at #BIF18, we re most excited to hear from ________ and you can expect to see us __________. Examples for Blank 2: Giving a company presentation or meeting with new partners Suggested Caption Copy: #Goals #BIF18 #Biotech To use: Double click the text to edit. Right click and save as picture
SUGGESTED POST #3 I just registered for @IamBiotech #BIF18-best conference to network with execs and investors focused exclusively on life sciences. www.bio.org/investorforum I just registered for @IamBiotech #BIF18- best conference to network with execs and investors focused exclusively on life sciences. http://bit.ly/2xAVi2I Positive investment trends for life sciences looking forward to @IamBiotech #BIF18 for networking and market outlook To use: Double click the text to edit. Right click and save as picture
SUGGESTED POST #4 Just signed up for partnering @IAmBiotech #BIF18. Last year 2760 meeting were scheduled. www.bio.org/events/bio-investor- forum/partnering I just signed up for partnering @IAmBiotech #BIF18 for face-to-face meetings exploring deals, trends and opportunities https://www.bio.org/events/bio-investor- forum/partnering To use: Right click and save as picture
2018 BIO INVESTOR FORUM DURING EVENT SOCIAL POSTS
2018 BIF PROGRAM- WED, OCT 17 Name Description Panelists Time Relevant Twitter Handles This panel reviews the current landscape of checkpoint inhibitor development Angele Maki, Merck & Co. Karin Jooss, Gritstone Oncology Eugene P. Kennedy, New Link Thomas W. Dubensky Jr., Tempest 8:30 9:40 AM @angelemaki @Merck @gritstoneonc @NLNKGenetics Navigating Checkpoint Inhibitors Clinical Results: Lessons for CEOs and Investors 9:45 10:40 AM Learning from Translational Research Successes to Attract Investment Exploring options to reduce the valley of death funding challenge Simone Fishburn, BioCentury Kevin Grimes, Stanford Univ Stephanie Marrus, UCSF Paul Laikind, ViaCyte @FishburnSimone @Stanford @skmarrus @UCSF @ViaCyte Using Microbiome-Based Therapies to Improve Patient Outcomes Discussion of microbiome- based approaches to improve patient outcomes David Berry, Flagship Karim Dabbagh, Second Genome Glyn Edwards, Summit Therapeutics Lihi Segal, Day Two Emma Taylor, Naked Biome Paul Miller, Synlogic 10:45 11:40 AM @FlagshipPioneer @karimdabbagh @Summitplc @NakedBiome @synlogic_tx Fireside Chat Ed Hurwitz, JD, MBA, Managing Director, MPM Capital Susanne Mulligan, Managing Director, BMO Capital Markets 12:00 1:45 PM @MPMCapital Reaching Chinese Investors: Considerations for an IPO in Hong Kong Cross-border perspectives on the appetite of China-based investors for biotechs Joshua Berlin, BioCentury Katherine Andersen, SVB Jie D Elia, BMS Michael Keyoung, C-Bridge Capital Keting Chu 2:00 2 :55 PM @BioPharmaJosh @SVB_Financial @bmsnews Impact of new rules for foreign direct investment. Louis Lehot, DLA Piper Mark E. Plotkin, Covington & Burling Lisa Schaefer, BIO Thilo Hanemann, Rhodium Group 3:15 4:10 PM @lehotlouis @CovingtonLLP @IAmBiotech @rhodium_group CFIUS and You: Understanding the Newly Expanded Regulatory Reviews of Cross-Border Investments View from the Board: Responding to an Acquisition Offer Discussion on one of the greatest challenges faced by a leadership team: responding to an acquisition offer. Corey Goodman, venBio Camille Samuels, Venrock Nina Kjellson, Canaan Partners Linda Grais, Ocera Therapeutics Michael J. O Donnell 4:15-5:10 PM @CamiSamuelsVC @nkjellson
2018 BIF PROGRAM- THURS, OCT 18 Name Description Panelists Time Relevant Twitter Handles The promise of anti-beta amyloid antibody in slowing cognitive decline in Alzheimer s patients Charles S. Ryan, Neurotrope Carole Ho, Denali Robert Paul, Alector Steven Braithwaite, Alkahest Julie Anne Smith, E-Scape Bio Emile Nuwaysir, BlueRock 8:30 9:40 AM @Neurotrope1 @Denalitx Expanding the Toolbox of Neurodegeneration Therapies @BlueRockTx Discussion on the use of cloud computing in biotechnology research Elliot Menschik, Amazon Craig Muir, Third Rock Matt Brauer, Third Rock Karina Chmeilewski, Third Rock Pablo Gersberg, BlackThorn Daphne Koller, insitro 9:45 10:40 AM @elliotmenschik @ThirdRockV Accelerating Biotech R&D Through Cloud Computing 10:45 11:40 AM Digiceuticals as a New Class of FDA- Approved Therapeutics: Investment & Partnering Opportunities Regulatory approach to digital therapeutics David Klein, Click Christopher Guiffre, Pear Jeffrey Abraham, Akili Interactive @ClickThera @Pear_Tx @AkiliLabs Fireside Chat with Rowan Chapman Head of Johnson & Johnson Innovation, CA Rowan Chapman, J&J 12:00 1:25 @JNJNews How Real-World Evidence Can Improve Clinical Trial Productivity Clinical trial design may be enhanced by digital real world data sources Ken Carson, Flatiron Christine Lemke, Evidation Gracie Lieberman, Genentech Komathi Stem, monARC Bionetworks 1:45 2:40 PM @flatironhealth @cklemke @Genentech @monARCbio Applying Artificial Intelligence to Improve Therapy Development Today Folding AI techniques into the development of new therapies Edward Painter, A2A Parma Josep Bassaganya-Riera, Landos Jeffrey Brewer, Bigfoot 3:00 3:55 PM @LandosBio @BigfootBiomed Market Outlook IPOs Ascendant and Watching M&A Valuations 2018 record flow of public and private offerings to biopharma and current deals and market trends 4:00 4:55 PM
LOREM IPSUM DOLOR SIT AMET, CONSECTETUR DOLOR ADIPISCING ELIT, SED DO EIUSMOD TEMPOR CONSECT INCIDIDUNT UT LABORE ETE DOLORE MAGNA ALIQUA. UT ENIM AD MINIM VENIAM, QUIS NOSTRUD EXERTION. #BIF18 @IAmBiotech @nkjellson- General Partner, Canaan Partners To use: Double click the text to edit. Right click and save as picture Click here to access speakers headshot photos
